ERBB2 and neoplasm: Studies have linked elevated HIF-1α expression to larger tumor sizes, higher tumor grades, increased proliferation markers (like Ki-67), and unfavorable molecular subtypes, such as HER2-positive and triple-negative breast cancers [48].